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Total hip arthroplasty (THA) represents one of the commonest surgical procedures in the orthopedic ﬁeld. Osteointegration of the
implant with native bone is essential for an optimal result; thus, the quality of the patient’s bone surrounding the implant (i.e., the
bone stock) is crucial. However, in some cases, the bone stock is insuﬃcient and needs to be improved with autologous grafts rich in
multipotent cells (i.e., from the iliac crest, from the head of the femur, or from the subchondral bone harvested from the
acetabulum) or allogenic frozen bone. It is not known if the harvesting site may inﬂuence the osteogenic potential of these cells.
Thus, our aim was to characterize and compare multipotent cells collected from the bone marrow, acetabular subchondral bone,
and trabecular bone on the femoral head with a focus on osteogenic diﬀerentiation. The cells from three sources had a
ﬁbroblast-like phenotype and expressed surface antigens CD73, CD90, and CD105 and are negative to CD11b, CD34, and
CD45. Although all these cells could be induced to diﬀerentiate into osteoblasts, chondrocytes, and adipocytes, they displayed
diﬀerent diﬀerentiation potentials. In osteogenic diﬀerentiation condition, the cells from the acetabulum had the lowest
accumulation of calcium deposit while the cells originated from the bone marrow and femur created a considerably increased
amount of the deposit. These ﬁndings were conﬁrmed by quantitative polymerase chain reaction (qPCR). In chondrogenic and
adipogenic conditions, bone marrow cells possessed a predominant diﬀerential capacity compared with the others, illustrated by
high collagen type II expression together with a cartilage-like lacuna structure and the presence of fat-speciﬁc markers,
respectively. To our knowledge, this is the ﬁrst study comparing and demonstrating that the progenitor cells obtained from
diverse surgical sites in hip replacement procedure share common characteristics of MSC but diﬀer about plasticity and may
provide rational for clinical application in cell therapy and bone grafting. The project number L1033 is registered with
ClinicalTrials.gov NCT03369457.
1. Introduction
Better health care system and nutrition have increasingly
improved life quality and expectancy that results in higher
number of elderlies who are also easily aﬀected from aging-
related problems including musculoskeletal diseases, i.e.,
osteoarthritis. According to the data published in OECD’s
report in 2017, the incidence of total hip arthroplasty
(THA) rose by 30% in the organization’s countries from
2000 to 2005 [1]. In particular, in 2010, the cases admitted
to THA in the United States were 2.1 million accounting to
0.83% population [2]. In the 20th century, John Charnley
ﬁrstly introduced his hip replacement technique; since then,
this technique has been continuously improved to overcome
the complications as well as to provide longevity of the pros-
thesis [3]. Its principle consists of the replacement of the
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damaged femoral head and acetabulum with a metallic pros-
thesis composed by a stem fused with a metal or ceramic ball
playing a role as the femoral head. An artiﬁcial socket is
placed in the reamed acetabulum. To facilitate smooth move-
ment between the “ball and socket,” a metal, ceramic, or plas-
tic liner is placed among them. For an optimal clinical result,
the implant needs to well integrate with the surrounding
bone; thus, the quality of bone and the level of the hip joint
(bone stock) are crucial in THA surgery. However, in some
cases of complex ﬁrst implants or in cases of revision surgery,
the bone stock may be insuﬃcient. Thus, a bone graft may be
required to restore the bone stock [4].
Bone autografts are considered the gold standard since
they prevent from graft rejection and they provide
osteoinduction (osteoblast stimulation, recruitment, and/or
diﬀerentiation) and osteoconduction (bone growth) [5];
however, the availability of bone autografts is limited in case
of big bone defects. Bone allografts, commonly morselized
and cancellous bones from femoral heads, are more avail-
able but they are decellularized scaﬀolds (due to the freezing
process); moreover, the risk of infectious disease transmis-
sion cannot be dismissed [5]. Ceramics, including hydroxy-
apatite and tricalcium phosphate, are osteoconductive
carriers, which are well known as bone substitutes in ortho-
pedic surgery because of safety, eﬀectiveness, and economic
costs [6, 7]. A clinical study performed by Gali et al. [8]
demonstrated that a mix of autologous bone marrow
aspirate and hydroxyapatite increased bone regeneration
in patients with maxillo-mandibular osseous defects. In the
orthopedic surgery context, in vivo study using bone marrow
cells and either tricalcium phosphate or hydroxyapatite-
coated acetabular cup in rabbits and goat models, respec-
tively, proved that these mixtures could improve osteoinduc-
tion and osteointegration of the grafts, decreasing aseptic
loosening [9, 10].
However, to our knowledge, there is still no study
addressing and comparing MSC obtained from diﬀerent
anatomic sites during THA procedure. Therefore, our tar-
get was to isolate and identify multipotent cells from the
acetabular subchondral bone, from fragments of femoral
cancellous bones and from bone marrow aspirate, which
was used as positive control. We took advantage of the
capability of MSC to adhere and grow on the plastic sup-
port; thus, we used neither density gradient media nor spe-
ciﬁc device to isolate the cells from the bone marrow [11].
Moreover, we also stimulated the bone chips to release the
cells without collagenase pretreatment which may aﬀect cell
behavior [12]; thus, the bone fragments were cultured in
the presence of ﬁbroblast growth factor-2 (FGF-2), which
improves MSC proliferation and diﬀerentiation [13, 14].
Next, multipotent cells were evaluated for cell proliferation,
colony-forming unit ﬁbroblast (CFU-f), and expression of
MSC cell surface antigens by ﬂow cytometric analysis.
Finally, in vitro diﬀerentiation of the cells into the osteo-
genic, chondrogenic, or adipogenic lineage was assessed
by speciﬁc histologic staining methods and by qPCR analy-
sis to measure expression of speciﬁc messenger RNA
(mRNA). Moreover, for osteogenic diﬀerentiation, IL1-β
was added to the osteogenic medium to better understand
the cell diﬀerentiation into osteoblast in the in vitro inﬂam-
matory condition.
We demonstrated that the anatomical site inﬂuences the
multipotent potential of MSC. Our results may give some
new hints for in vivo research and stem cell therapy for bone
tissue engineering.
2. Materials and Methods
Approval was obtained from the Ethical Committee of
IRCCS Istituto Ortopedico Galeazzi.
For patient selection, 9 patients undergoing THA proce-
dure at Galeazzi Orthopedic Institute (Milan, Italy) were
enrolled in the study after signing an informed consent.
Inclusion criteria were age between 50 and 80 years old;
body mass index (BMI) was between 18 and 30 kg/m2;
there was no history of metabolic bone disease; there was
no history of infectious diseases (HIV, HCV, HBV, or
Treponema pallidum) or inﬂammatory joint disease (i.e.,
rheumatoid arthritis).
2.1. Cell Isolation and Explant Culture. Bone marrow aspirate
from the femoral canal, pieces of reamed acetabular sub-
chondral bones, and fragments of femoral cancellous bones
were obtained from the patients. Samples were stored at
4°C and processed within 5-6 hours (h) from surgery.
The bone marrow was diluted 1 : 1 with sterile 1x
phosphate-buﬀered saline (PBS) and centrifuged at 1,700g
for 10min at room temperature (RT). The supernatant was
carefully removed. This step was repeated twice. Cell pellet
was resuspended in PBS, and the ﬁrst test sample was diluted
1 : 10 volume/volume (v/v) in PBS (suspension A). From the
suspension A, the second test sample was taken and mixed
1 : 1 v/v in 4% acetic acid (suspension B) and incubated for
1 minute (min) to eliminate red blood cells and white blood
cells. From the suspension B, the third test sample was taken
and mixed 1 : 1 v/v in trypan blue to stain dead cells. Nucle-
ated cells were counted and plated at a density of 5 × 104
cells/cm2 in complete medium containing alpha minimum
essential medium (αMEM, Life Technologies), 10% v/v fetal
bovine serum (FBS, Euroclone), and 1% v/v penicillin/strep-
tomycin/glutamine (P/G/S, Life Technologies) supplemented
with 1ng/ml recombinant human FGF-2 (R&D Systems) on
T-175 ﬂasks. The primary cells at passage 0 (P0) were incu-
bated at 37°C and 5% CO2 without disturbance for 1 week.
Then, medium was changed twice per week. When cells
reached subconﬂuence, they were detached by using 1x tryp-
sin/ethylenediaminetetraacetic acid (trypsin/EDTA, Life
Technologies) and passaged up to P2. Acetabular and femo-
ral bone pieces were intensively washed in PBS to remove
blood and then fragmented. The minced chips were washed
again in PBS and then maintained in complete medium
supplemented with 1ng/ml FGF-2 on 6-well plates. The
medium was changed two times every week. When cells
released from the pieces reached subconﬂuence, trypsi-
n/EDTA was added to the wells to trypsinize cells (the bone
chips were in contact with trypsin/EDTA as well). The cells
were expanded up to P2. The bone pieces were discarded
after two times in trypsin/EDTA treatment.
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2.2. Colony-Forming Unit Fibroblast (CFU-f) Assay. Cells at
P1 were plated at a density of 1 × 103 cells/10 cm dish in com-
plete medium supplemented with FGF-2. Each experiment
was performed in triplicate, and the medium was changed
twice per week. After two weeks, cells were washed with 1x
PBS and then ﬁxed in methanol and absolute ethanol (1 : 1 v
/v) for 10min followed by the coloration in 0.5% g/ml crystal
violet solution (solvent was 20% v/v methanol) (Sigma) for
15min at room temperature (RT). Then, cells were washed
twice with PBS and running tap water to remove the exces-
sive stain. The dishes were air-dried, and only colonies con-
taining more than 50 cells were counted. Results were
expressed as average of at least four independent experiments
performed on at least four diﬀerent primary cell cultures +
standard error of the mean (SEM) values. Photos of the
dishes were taken using the scanner Epson V200 (Epson).
2.3. Cell Proliferation and Viability
2.3.1. Crystal Violet Stain. Crystal violet stain was performed
to determine cell proliferation in monolayer culture. Cells
were plated at a density of 1 5 × 103 cells/well in complete
medium consisting of FGF-2 in quintuplicate on 96-well
plates. At each time point, cells were washed once with PBS,
ﬁxed and stained with 50μl colorant solution (0.75% g/ml
crystal violet (Sigma), 0.35% g/ml NaCl, 32.3% v/v absolute
ethanol, and 35% v/v formalin 10%) for 20min at RT, and
ﬁnally washed 5 times with water and air-dried. Photos were
taken by using the bright ﬁeld microscope (Leica). 100μl of
eluent solution (50% v/v absolute ethanol and 1% v/v acetic
acid) was added to each well, and the dye absorbance was
measured at 570nm wavelength using the microplate reader
model 680 (Bio-Rad). The experiment was repeated at least
three times on at least three diﬀerent primary cell cultures.
2.3.2. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide) Stain. MTT stain was used to investi-
gate cell viability and proliferation cultured as pellet in
suspension culture (see 2.5.2). Cultures were performed in
15ml falcon tubes at a density of 5 × 104 cells/0.5ml/tube
up to 21 days. The experiment was repeated at least three
times in triplicate on at least three diﬀerent primary cell cul-
tures. For the stain, tubes were centrifuged at 1,700g for
5min, pellets were washed once with PBS, and 0.5ml
serum-free medium supplemented with 25μl of MTT
(Sigma) of 5mg/ml stock solution was added to the tubes.
Cells were incubated for 1 h in the dark. Then, pellets were
washed twice with PBS. 1ml of absolute ethanol was added
to each tube; tubes were vortexed for 1min to solubilize the
purple formazan. The absorbance of the colorant was mea-
sured at 570/670 nm wavelength by using spectrophotometer
Ultrospec 2100 (Amersham Biosciences).
2.4. Flow Cytometric Analysis. When cells reached 80% of
conﬂuence, they were detached by using trypsin/EDTA and
resuspended in stain buﬀer composed of 1x PBS and 3% v
/v FBS that block nonspeciﬁc antigens. The cell suspension
was divided into polystyrene round bottom tubes at a density
of 105 cells/tube. The incubation was performed at 4°C for
20min in the dark using monoclonal antibodies against
CD11b (clone ICRF44), CD34 (clone 581), CD45 (clone
HI30), CD73 (clone AD2), CD90 (clone 5E10), and CD105
(clone 266). For automatic compensation, anti-mouse Ig,
κ/negative control compensation particle set was used. All
the reagents were purchased from BD Biosciences. Further-
more, to better interpret the results and gating, we also used
the ﬂuorescence minus one (FMO) method, where tubes
contain all the antibodies except the one which is being mea-
sured. After staining, the cells were washed with PBS, resus-
pended in 0.5ml stain buﬀer, and run through ﬂow
cytometer BD FACS Canto II (BD Biosciences). Data were
analyzed by software FlowJo.
2.5. In Vitro Diﬀerentiation
2.5.1. Adipogenic Diﬀerentiation. To induce adipogenic
diﬀerentiation, cells were cultured in complete medium sup-
plemented with FGF-2 at 5 × 104 cells/well on 24-well plates
or 3 × 105/well on 6-well plates for Oil Red O stain and
qPCR, respectively. For Oil Red O stain, the experiment
was performed in triplicate. When the cells were conﬂuent,
the medium was changed to adipogenic medium which is
complete medium composed of 50μg/ml ascorbic acid,
10-7 M dexamethasone, 5 ng/ml insulin, 0.5mM 3-isobu-
tyl-1-methyl xanthine, and 0.1mM indomethacin. All the
reagents were bought from Sigma. The complete medium
was used as control. The induction media were freshly pre-
pared and changed two times per week. The induction lasted
for 3 weeks.
2.5.2. Chondrogenic Diﬀerentiation. Induction of chondro-
genic diﬀerentiation was performed as previously described
[15] with little modiﬁcation. In this study, cells were sus-
pended in 15ml falcon tubes in complete medium containing
50μg/ml ascorbic acid (Sigma), 10-7 M dexamethasone
(Sigma), and 10ng/ml recombinant human transforming
growth factor-β1 (TGF-β1, R&D Systems) at a density of
5 × 105 cells/0.5ml/tube for immunohistochemistry and tolu-
idine blue staining, 5 × 104 cells/0.5ml/tube for MTT assay,
and 3 × 105 cells/0.5ml/tube for qPCR. The media were
changed twice per week. The cultures were maintained up
to 21 days.
2.5.3. Osteogenic Diﬀerentiation. To stimulate osteogenic dif-
ferentiation, cells were ﬁrstly cultured in complete medium
supplemented with FGF-2 at 5 × 104 cells/well on 24-well
plates or 3 × 105 cells/well on 6-well plates for Alizarin Red
S stain and qPCR, respectively. For Alizarin Red S stain, the
experiment was carried out in triplicate. When the cells
reached conﬂuence, the medium was switched to osteogenic
medium (OM) which is complete medium containing
50μg/ml ascorbic acid (Sigma), 10-7 M dexamethasone
(Sigma), and 10mM β glycerolphosphate (Merck). More-
over, 50 pg/ml IL1-β (R&D Systems) was also added to the
OM. The concentration of IL1-β used for this experiment
procedure was inferred from literature data [16–18]. The
complete medium was used as control. OM and OM supple-
mented with IL1-β were prepared freshly and added to the
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cells twice per week. The diﬀerentiation was prolonged for
3 weeks.
2.6. Cell Staining and Immunohistochemistry
2.6.1. Oil Red O Stain. Oil Red O coloration was used to stain
the lipid droplets formed by adipocytes. The working stain-
ing solution was prepared freshly (1-24 h) before the experi-
ment by mixing 6 : 4 v/v of 0.5% Oil Red O solution (Sigma)
and distilled water, and then the solution was ﬁltered to dis-
card the precipitates. The cells were washed once with PBS,
ﬁxed in 10% formalin for 10min, and washed again with
PBS to remove formalin. PBS was completely removed
followed by coloration in the working solution for 10min at
RT. Then, cells were washed once in 60% isopropanol solu-
tion for 30 seconds (s) and rinsed three times with distilled
water. Photos of the cells with stained droplets were immedi-
ately taken by using the bright ﬁeld microscope (Leica).
Then, the water was removed, and the stained droplets were
dissolved in isopropanol solution (1ml/well). Dye absor-
bance was measured at 510 nm wavelength using spectro-
photometer Ultrospec 2100.
2.6.2. Toluidine Blue O Stain. Toluidine blue O stain was
used to observe the cartilage matrix. The colorant stains
nuclei as blue and proteoglycans and glycosaminoglycans
as light blue to violet. Cell pellets were washed twice in
PBS, ﬁxed in 10% formalin for 15min at RT, then included
in paraﬃn, and sliced into 5μm sections on the SuperFrost
Plus adhesion slides (Thermo Fisher Scientiﬁc) which were
previously coated with poly-L-lysine (Sigma) to prevent sec-
tion from detachment.
For the coloration, slides were deparaﬃnized and dipped
in the 0.2% w/v toluidine blue O solution (the powder was
provided by Serva, Germany) for 5min at RT followed by
rinsing in distilled water twice, each time for 5min and
mounted with DPX mounting medium.
2.6.3. Immunohistochemistry. The slides were prepared as
mentioned above. After deparaﬃnization, antigen retrieval
process was performed by immersing the slides in boiling
citrate buﬀer (pH6) and cooled down at RT for 20min. Next,
sections were permeabilized in 0.2% Triton in PBS for 10min
at RT, washed three times with PBS, each for 5min, and incu-
bated in 4% hydrogen peroxide for 30min at RT to block the
endogenous peroxidase activity. Then, slides were incubated
in hyaluronidase type II (Sigma) at a concentration of
1mg/ml in PBS (pH6) for 30min at 37°C to break down
the matrix and blocked in 10% FBS for 1 h at RT followed
by incubating with primary antibodies anti-collagen type I
(ab138492, Abcam) and anti-collagen type II (ab34712,
Abcam) for 16 h at 4°C. After washing with PBS, the sections
were incubated with anti-rabbit biotinylated antibody
(1 : 500, Dako) for 30min at RT, washed in PBS, incubated
in streptavidin peroxidase (Dako) for 30min at RT, then
stained with 3,3′-diamino-benzidine (DAB, Dako) for
3min, counterstained in Mayer’s hematoxylin for 1min,
submerged in distilled water containing some drops of 1M
NH4OH (Sigma) for bluing, and mounted with DPX
mounting medium. Photos were taken by using a light
microscope (DM5000 B, Leica).
2.6.4. Alizarin Red S Stain. To observe the mineralization of
the induced cells in osteogenic diﬀerentiation, Alizarin Red
S stain was used. Brieﬂy, cells were washed once with PBS,
ﬁxed in 10% formalin for 10min, washed twice with PBS,
stained in 2%w/v Alizarin Red S solution pH4.2 (the powder
was purchased from Sigma) for 10min at RT, and washed
with distilled water. The plates were air-dried later. To dis-
solve the calcium deposits, 1ml of elution solution contain-
ing 20% methanol and 10% acetic acid was added to each
well and incubated for 30min at RT with gentle pipetting
and shaking. The dye’s absorbance was measured at 450nm
wavelength. The experiment was repeated at least six times
on at least ﬁve diﬀerent primary cell cultures.
2.7. qPCR. qPCR was performed to examine the expression of
mRNA extracted from the diﬀerentiated cells. Total RNA
was isolated by using RNeasy Mini Kit (Qiagen). NanoDrop
8000 (Thermo Fisher Scientiﬁc) was utilized to assess RNA
quality and purity. If required, RNA was precipitated by mix-
ing with 1 : 3 v/v cold absolute ethanol and 1 : 0.1 v/v 3M
sodium acetate and incubating for 16 h at −80°C. 1μg of
RNA was reversely transcribed by using ImProm II reverse
Transcription System (Promega) on thermal cycler (Euro-
clone). Ampliﬁcation of cDNA was carried out using
PowerUp SYBR master mix (Thermo Fisher Scientiﬁc) and
primers were purchased from Euroﬁns (Germany) on 7500
Fast Realtime PCR System (Applied Biosystems). The
sequences of primers are listed in Table 1. The reaction plates
were run in three stages: holding stage starts at 50°C for 20 s
and then 95°C for 10min, cycling stage was repeated for 40
cycles where the reactions were remained at 95°C for 15 s
and then 60°C for 1m, and ﬁnally in the melt curve stage,
the plates were set at 95°C for 15 s, followed by 60°C for
1m, 95°C for 30 s, and 60°C for 15 s. Relative gene expression
was done according to comparative method [19] where data
were presented as 2−ΔΔCt or 2−ΔCt with ΔCt = Ct (gene of
interest)-Ct (housekeeping gene) and ΔΔCt = ΔCt at day
n-ΔCt at day 0, n = number of days of diﬀerentiation.
2.8. Statistical Analysis. All data are presented as means and
standard error of the mean (SEM). Statistical analysis was
performed by using unpaired t-test online application of
the GraphPad software (https://www.graphpad.com/quick
calcs/ttest1); for analysis of cell proliferation in adherent
culture condition, the nonparametric Mann–Whitney U test
with two-tailed hypothesis was applied (https://www.socs
cistatistics.com/tests/mannwhitney/). Analysis is considered
signiﬁcant if p value is <0.05.
3. Results
3.1.Morphology,Proliferation,andPhenotypicCharacterization
of the Cells in Adherent Conditions. The ﬁrst criteria to iden-
tify MSC is their adherence to a plastic support [20]. Taking
advantage of this basic MSC feature, we used a very simple
method to isolate MSC from the bone marrow (BMC) and
from femoral (FC) and acetabular (AC) bone chips in the
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explant cultures. Bone marrow samples were washed and left
without disturbance; after one week, the adherent cells were
observed while for explant culture, after approximately two
weeks, the ﬁrst ﬁbroblast-like cells were released from the
chips (Figure 1(a)). Moreover, cells also grew to form colo-
nies starting from low plating density as demonstrated in
Figure 1(b). After plating cells for 14 days, AC showed a
striking capacity of colony formation compared with the cells
from the bone marrow and femur (1.5- and 1.6-fold increase,
respectively). Cell growth was also investigated by staining
the cells with crystal violet solution following time course.
Figure 1(c) shows a signiﬁcant proliferation of AC and FC
compared with BMC (p = 0 0076 and p = 0 0146, respec-
tively). The diﬀerence in cell proliferation was also illustrated
in Figure 1(d): day 6 of culture cells from the bone marrow
still did not reach conﬂuence. In contrast, AC and FC were
tight, and in particular, AC appeared much smaller than
the others in spite of the same seeding density inferring a fas-
ter growth.
To more comprehensively characterize the cell popula-
tion from the three sources, we used ﬂow cytometry to eval-
uate expression proﬁle of markers (Figure 1(e)). BMC
possessed a lower percentage of markers for hematopoietic
cells and endothelial cells such as CD11b, CD34, and CD45
compared with AC and FC, without signiﬁcant diﬀerence.
Moreover, there was no signiﬁcant variation in expression
of the cell surface markers commonly used to deﬁne MSC
such as CD73, CD90, and CD105.
3.2. In Vitro Adipogenic Diﬀerentiation. To reveal the in vitro
formation of adipose tissue, the cells were exposed to adipo-
genic medium for 21 days. After 7 days, the small fat vacu-
oles were detected by Oil Red O staining, and their size and
density increased over time as shown in Figure 2(a). Quan-
tiﬁcation of dyed fat droplets was conducted by measuring
the absorbance at 510nm, and results were presented as
fold increase in absorbance between the induced cells and
the control cells. The chart in Figure 2(a) proved that even
at early treatment time, there is still signiﬁcant increase in
adipogenic capacity of the cells in respect of day 0. The cells
from three sources have similar expression of fat droplets.
Therefore, qPCR was performed to further evaluate gene
expression of two adipogenic markers: LPL and PPARG
(Figure 2(b)). Interestingly, all three cell types showed a
higher LPL expression than PPARG. Both BMC and FC
showed an increase expression of LPL over the time, with
a signiﬁcant diﬀerence between the induced cells and con-
trol cells starting from day 14 (BMC) to day 7 (FC), and
while LPL expression in AC reached a signiﬁcant diﬀerence
at day 7, it reached peak at day 14 and then decreased at
day 21. PPARG expression in induced FC over time was
higher compared with that in the control cells but not sta-
tistically signiﬁcant.
We also compared LPL and PPARG among the three cell
types. BMC showed a higher expression of both LPL and
PPARG at the latest time point, as shown in the last two
charts of Figure 2(b). Moreover, the diﬀerence in PPARG
Table 1: Primer sequences for qPCR (F/R: forward/reverse).
Human gene Sequence (5′-3′) Product size (bp)
Housekeeping genes
18S rRNA
F: GTAACCCGTTGAACCCCATT
151 [21]
R: CCATCCAATCGGTAGTAGCG
GAPDH (NM_001289745.2)
F: ATGGGGAAGGTGAAGGTCG
70
R: TAAAAGCAGCCCTGGTGACC
Adipogenic diﬀerentiation
PPARG (NM_001354667)
F: GGCTTCATGACAAGGGAGTTTC
74
R: AACTCAAACTTGGGCTCCATAAAG
LPL (NM_000237.2)
F:GAGGTACTTTTCAGCCAGGATGTAAC
82
R: AGCTGGTCCACATCTCCAAGTC
Chondrogenic diﬀerentiation
COL1A1 (NM_000088.3)
F: CAGCCGCTTCACCTACAGC
83
R: TTTTGTATTCAATCACTGTCTTGCC
COL2A1 (NM_001844.5)
F: GGCAATAGCAGGTTCACGTACA
79
R: CGATAACAGTCTTGCCCCACTT
Sox9 (NM_000346.3)
F: AGTACCCGCACTTGCACAA
68
R: CTCGTTCAGAAGTCTCCAGAGCTT
Osteogenic diﬀerentiation
BGLAP (osteocalcin) (NM_199173.5)
F: CGCCTGGGTCTCTTCACTAC
143
R: CTCACACTCCTCGCCCTATT
SPP1 (osteopontin) (NM_001251830.1)
F: CTCAGGCCAGTTGCAGCC
81
R: CAAAAGCAAATCACTGCAATTCTC
ALP (NM_000478.6)
F: ACCACCACGAGAGTGAACCA
79
R: CGTTGTCTGAGTACCAGTCCC
18S rRNA: 18S ribosomal RNA; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; PPARG: peroxisome proliferator-activated receptor gamma; LPL:
lipoprotein lipase; COL1A1: collagen type I alpha 1 chain; COL2A1: collagen type II alpha 1 chain; BGLAP: bone gamma-carboxyglutamate protein; SPP1:
secreted phosphoprotein 1; ALP: alkaline phosphatase.
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Figure 1: Cell morphology, proliferation, and marker expression in monolayer culture. (a) Morphology of the cells in culture at day 21. The
middle and the right photos show the cells released from the bone chips (on the top left and bottom left corner, respectively) and expanding,
scale bar 50 μm. (b) Cell colonies stained with crystal violet solution after plating 14 days showing a 1.5- and 1.6-fold increase in the cells
derived from the acetabulum compared with the cells from the bone marrow and femur, respectively. Data are shown by the average +
SEM of at least four independent experiments performed in triplicate from at least four diﬀerent primary cultures, ∗∗p < 0 006. (c)
Proliferation curve of the cells in adherent culture determined by measuring absorbance of the cells stained with crystal violet at 570 nm
wavelength. Results are the average + SEM of at least three experiments done in quintuplicate from at least three diﬀerent cell cultures
(∗p = 0 0146, ∗∗p = 0 0076). (d) Morphology of cells stained with crystal violet in culture at day 6, scale bar 50 μm. (e) Charts showing cell
marker expression analyzed by ﬂow cytometry. The expression percentage of the antigens is the average + SEM from three independent
experiments of three diﬀerent primary cell cultures (p > 0 05).
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Figure 2: Adipogenic diﬀerentiation. Conﬂuent cells were induced in adipogenicmedium (AM) for threeweeks to diﬀerentiate into adipocytes;
the control (CTR) cells were maintained in complete medium. (a) Oil Red O stain. Cells were stained with Oil Red O solution, which marks fat
droplets into red color. Photos of the CTR cells are not shown, scale bar 50μm. Quantiﬁcation was determined by measuring the absorbance
of the stained cells at 510 nm (n = 5, ∗p < 0 05, ∗∗p ≤ 0 003, ∗∗∗p ≤ 0 0003). (b) qPCR results. Expression of the adipocytic marker genes LPL
and PPARG of the cells cultured in CTR and AM conditions. Data are presented as 2−ΔCt + SEM value. The lowest charts show the expression
comparison of these markers among the cells originated from all three sources (n = 3, ∗p < 0 05, ∗∗p ≤ 0 0092).
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expression is statistically signiﬁcant after 21 days between
BMC and AC.
3.3. In Vitro Chondrogenic Diﬀerentiation. To unravel the
chondrogenic capacity of the cells, we used the pellet culture
method in three-dimensional suspension condition, which
more closely mimics the in vivo cartilaginous microenviron-
ment. First, we studied cell proliferation in two-dimensional
adherent conditions (Figure 1(c)). The evaluation of cell via-
bility and/or proliferation in suspension conditions is also
recommended to predict cell behavior since diﬀerentiation
in three-dimensional environment may interfere with prolif-
eration. Figure 3(a) represents cell proliferation in suspen-
sion: BMC maintained almost unchanged growth while AC
and FC continuously proliferated. At day 21, FC displayed
an impressive growth capacity compared with BMC and
AC (3.76- and 1.69-fold increase, respectively).
We then proceeded with the analysis of the cartilaginous
phenotype by analyzing glycosaminoglycan deposition and
the expression of cartilaginous markers, namely, collagen
type II and Sox9. Unfortunately, in vitro chondrogenesis
often produces ﬁbrocartilage characterized by the expression
of collagen type I [22]; therefore, in this study, we also eval-
uated its expression. Toluidine blue O stain was used to
observe the formation of extracellular matrix of the pellet.
Figure 3(b) shows that all of the cells were able to form pel-
lets, but the intensity of the stain changed among the groups.
BMC pellets exhibited a localized violet area at day 14 sug-
gesting an initial formation of the in vitro cartilage matrix;
after 21 days of treatment, the violet zone expanded and cov-
ered most of the section. More interestingly, we also observed
the cartilage typical lacuna structure where the chondrocytes
are embedded (insets in Figure 3(b)). On the other hand, AC
and FC only showed light blue coloration of the matrix with-
out any lacuna structure even at the longest time point. Pro-
duction of collagen type I and collagen type II was analyzed
by immunohistochemistry (Figure 3(b)). At day 14, BMC
and FC expressed a stronger signal for collagen type II than
AC; however, at day 21, FC showed much less intensiﬁed
signal for collagen type II than BMC. Collagen type I was
unexpectedly present on all cell pellets suggesting the unse-
lective diﬀerentiation despite a long culture in three-
dimensional conditions.
We also investigated gene expression for collagen type I,
collagen type II, and chondrogenic speciﬁc marker Sox9 by
qPCR (Figure 3(c)). At day 21 of culture, collagen type I
expression decreased in BMC and FC compared with the ear-
lier time point; that result was not found in AC, though a sig-
niﬁcant diﬀerence was not detected. More importantly, after
21 days of induction, collagen type II expression in BMC cells
reached the peak and was signiﬁcantly higher compared to
the AC and FC cell sources (6.58- and 6.78-fold increase,
respectively). BMC showed an increase in Sox9 expression
but not in a signiﬁcant manner, while in AC and FC, the
expression markedly decreased with time. These ﬁndings
conﬁrmed the abovementioned histological observation.
3.4. In Vitro Osteogenic Diﬀerentiation. The conﬂuent cells
were induced to diﬀerentiate into osteoblasts in OM or OM
supplemented with IL-1β conditions. The Alizarin Red stain
in Figure 4 revealed that even under long experimental time,
AC are the most unresponsive cells to both conditions OM
and IL-1β while BMC and FC started to react to the induc-
tion from day 7. In both OM and IL-1β conditions, starting
from day 14, AC had the lowest accumulation of calcium
with respect to the other two cell sources (the last two charts
in Figure 4). In OM condition, BMC showed the highest level
of mineral deposits, while in IL-1β condition from day 14, FC
released the most elevated amount of deposits; although in
both conditions, no signiﬁcant diﬀerence was measured
between these two groups. The staining also veriﬁed that
the presence of IL-1β at appropriate concentration did not
interfere with the mineralization of the cells in osteogenic dif-
ferentiation medium.
We also performed qPCR (Figure 5) to fully investigate
gene expression of osteogenic markers such as ALP (early-
stage osteogenesis), osteopontin (middle-stage osteogenesis),
and osteocalcin (late-stage osteogenesis) [23]. BMC and FC
when exposed to OM or IL-1β conditions highly expressed
ALP gene at the earliest time point (day 7) and then the
expression decreased over time.
In AC, ALP expression at the diﬀerent time points was
even lower compared with day 0 but without signiﬁcant dif-
ference. In FC, a signiﬁcant upregulation in osteopontin
gene expression was noticed at day 7, whereas in BMC
and AC, a signiﬁcant diﬀerence was observed later at day
14 and day 21, respectively. Moreover, a signiﬁcant upregu-
lation in osteocalcin gene expression was detected only in
FC at days 14 and 21 when compared with day 0. As men-
tioned previously, we compared cells cultured in a standard
OM medium with cells cultured in OM supplemented with
50 pg/ml IL-1β, to test its possible role in increasing osteo-
genesis. By Alizarin staining, we did not observe a suﬃcient
diﬀerence in mineralization between two conditions OM
and IL-1β (Figure 4), whereas by qPCR, we noted that IL-
1β when used at 50 pg/ml concentration in osteogenic
medium may increase osteopontin expression in BMC and
FC at day 14 and day 7, respectively.
The charts on the last two rows in Figure 5 compared
ALP, osteopontin, and osteocalcin gene expression of the
cells in each condition. In OM condition, BMC and FC
showed a signiﬁcant upregulation in ALP gene expression
when compared with AC; in particular, in FC, the signiﬁcant
diﬀerence was present at day 7. Osteopontin gene expression
was signiﬁcantly upregulated in BMC when compared with
AC (p = 0 0403 at day 7 and p = 0 0111 at day 14). Osteocal-
cin gene expression did not signiﬁcantly change among the
three diﬀerent cell sources. Finally, in OM standard condi-
tions, BMC generally showed an upregulation of all the three
markers when compared with FC, though without a signiﬁ-
cant diﬀerence.
In OM+IL-1β condition, BMC and FC also had signiﬁ-
cantly upregulation in ALP and osteopontin gene expression
compared with AC. Moreover, we observed only a signiﬁcant
diﬀerence between BMC and FC in osteopontin gene expres-
sion at day 14; in particular, the bone marrow cells yielded a
higher amount of osteopontin (p = 0 0023). All these ﬁndings
suggest that the osteogenic potential of the bone marrow-
8 Stem Cells International
Proliferation in suspension
0
0.1
0.2
0.3
0.4
0.5
0 7 14 21
A
bs
or
ba
nc
e a
t (
57
0-
67
0)
 m
m
Days of differentiation
Bone marrow
Acetabulum
Femur
⁎
⁎
⁎
(a)
Col IICol II Col ICol I TBTB
Day 14 Day 21
Bo
ne
 m
ar
ro
w
 
A
ce
ta
bu
lu
m
Fe
m
ur
(b)
Collagen type II
0
1
2
3
4
5
0 14 21
Days of differentiation
Collagen type I Sox9
Bone marrow
Acetabulum
Femur
Fo
ld
 in
cr
ea
se
 (2
−
ΔC
t  v
al
ue
)
0
5
10
15
20
0 14 21
Days of differentiation
Fo
ld
 in
cr
ea
se
 (2
−
ΔC
t  v
al
ue
)
0
0.5
1.0
1.5
2.0
2.5
0 14 21
Days of differentiation
Fo
ld
 in
cr
ea
se
 (2
−
ΔC
t  v
al
ue
)
⁎
⁎
⁎
⁎⁎ ⁎⁎
⁎⁎
⁎⁎
⁎⁎
⁎
⁎⁎⁎ ⁎⁎⁎
⁎⁎⁎
⁎⁎⁎
⁎
⁎
(c)
Figure 3: Chondrogenic diﬀerentiation in suspension condition. Cells were induced in chondrogenic medium in suspension condition to
form pellets up to 21 days and then analyzed. (a) Proliferation of the cells determined by MTT assay. Absorbance of the stained cells was
measured at 570 nm and 670 nm (reference wavelength). Results are the average + SEM value of at least three experiments performed in
triplicate from at least three independent cell cultures. (b) Photos of toluidine blue O (TB) stain and immunohistochemistry for collagen
type I (Col I) and collagen type II (Col II). Toluidine blue stains the matrix from light blue to violet and dyes the nuclei to dark blue. The
white dash line covers the most violet zone on the photo showing the coloration of the more intensiﬁed cartilage matrix. The insets better
illustrate cartilaginous matrix where chondrocytes are trapped in the lacunae. The brown color indicates the expression of collagen type I
and collagen type II. Scale bar: insets 5μm, others 25μm. (c) qPCR results. Expression of the cartilage markers collagen type I, collagen
type II, and Sox9. Data are presented as 2−ΔΔCt + SEM value (n = 3, ∗p < 0 05, ∗∗p ≤ 0 0025, ∗∗∗p ≤ 0 0007).
9Stem Cells International
derived cells is quite competitive compared with that of pro-
genitor cells released from femoral bone fragments.
4. Discussion
The heterogeneity of MSCs, which not only diﬀer from donor
to donor but also vary depending on the source of tissues, has
been discussed in previous works [24–26]. Therefore, the
search and selection of the best source of MSCs for a speciﬁc
clinical application is required. In particular, to our knowl-
edge, little work has been performed to compare the multipo-
tency of cells obtained from the surgical sites during hip
arthroplasty. In this study, we isolated and compared cells
derived from diﬀerent tissues in hip replacement procedure:
the bone marrow collected from the femoral canal (as posi-
tive control, BMC), pieces of acetabular subchondral bone
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Figure 4: Osteogenic diﬀerentiation determined by Alizarin Red S coloration. Conﬂuent cells were cultured and induced in osteogenic
medium (OM) or OM supplemented with 50 pg/ml IL-1β (IL-1β) up to 21 days. The control (CTR) cells were maintained in complete
medium. Alizarin Red S solution was used to recognize calcium deposits. Quantiﬁcation was performed by measuring the absorbance of
the stained deposits at 450 nm wavelength. The lowest charts show the comparison in quantiﬁcation among the cells originated from all
three sources in both OM and IL-1β conditions. Data are the average + SEM value of at least six independent experiments carried out in
triplicate from at least six diﬀerent cell cultures (∗p < 0 05, ∗∗p < 0 009, ∗∗∗p < 0 0008).
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(AC), and fragments of trabecular bone from the femoral
neck and head (FC). The aim of our work was to analyze
potential diﬀerences between cell sources that may be applied
for new techniques of bone stock restoration. Our study
proves that three types of cells share MSC identity, but they
show diﬀerences in cell lineage diﬀerentiation that may indi-
cate variations in cell commitment.
CFU-f assay has been considered the gold standard to
evaluate the stemness of progenitor cells [27, 28]; namely,
starting from a scarce plating number, the progenitor cells
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Figure 5: Osteogenic diﬀerentiation analyzed by qPCR. Expression of the bone markers ALP (early-stage diﬀerentiation), osteopontin
(middle-stage diﬀerentiation), and osteocalcin (late-stage diﬀerentiation). The charts on the last two rows show the comparison in marker
expression of the cells derived from three sources in both conditions OM and IL-1β. Data are shown as percentage of fold increase
2−ΔΔCt + SEM value (n = 3, ∗p < 0 05, ∗∗p ≤ 0 0061, ∗∗∗p ≤ 0 0008).
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were able to attach the plastic culture dish, proliferate, and
form colonies. Cells released from pieces of the acetabulum
showed a great ability of colony formation compared with
the cells from the bone marrow and femur. This ﬁnding is
consistent with the proliferation assay in adherent culture
demonstrating the striking growth capacity of AC. We did
not observe a signiﬁcant diﬀerence in cell marker expression,
as all of the cell types were negative for hematopoietic
markers (CD11b, CD34, and CD45) and positive for MSC
markers (CD73, CD90, and CD105).
The iliac crest bone marrow has been accepted as “gold
standard” source for MSC isolation [29, 30] because of easy
access and high content of red marrow. The bone marrow
obtained from femoral canal is occupied by red marrow
and also yellow marrow composed of adipocytes. Even
though all of the cells isolated from the three sources formed
visible fat droplets, the presence of primitive adipocytes
could be an explanation for the predominant expression of
fat gene markers LPL and PPARG of BMC compared to
AC and FC when exposed to adipogenic medium. The con-
cept of the bone marrow “stem cell niche”, where the bone
marrow represents the microenvironment where MSCs and
hematopoietic stem cells (HSCs) reside, is well known [31–
34]. In the niche, the MSC is a main player [32], which inter-
acts, orchestrates, and maintains the homeostasis of the
microenvironment. Thus, MSCs are more naïve and are able
to quickly respond to the microenvironment when diﬀeren-
tiation is needed to replace dead or damaged cells. Indeed,
under a chondrogenic stimulus, BMC were able to form
the in vitro lacunae with strong expression of collagen type
II and high quantity of glycosaminoglycans, whereas AC
and in particular FC displayed an inferior chondrogenic
potential as shown by histology and by gene expression.
Therefore, both AC and FC progenitor cells may diﬀerenti-
ate into chondrocytes if properly stimulated, but their intrin-
sic chondrogenic potential is inferior compared with bone
marrow-derived cells. In osteogenic conditions, we noticed
signiﬁcant diﬀerences between the cell sources: quantiﬁca-
tion of Alizarin Red S staining demonstrated that both
BMC and FC have a signiﬁcantly higher capacity to form
calcium deposits. This was also conﬁrmed by gene proﬁle
of osteogenic markers ALP, osteopontin, and osteocalcin.
Thus, cells harvested from the trabecular bone of femoral
head and neck possess a higher intrinsic osteogenic potential
compared with cells isolated from the acetabular subchon-
dral bone.
We also proved that an inﬂammatory environment,
obtained by supplementing the osteogenic medium with
IL1-β at low dose (50 pg/ml), did not aﬀect the osteogenic
diﬀerentiation. Moreover, our results suggest that a con-
trolled inﬂammatory stimulus may promote the osteogenic
potential of multipotent cells without leading to cell death
or tissue damage.
In summary, our study analyzed and compared the mul-
tipotency of cells derived from diﬀerent anatomical sites dur-
ing hip replacement surgery: the bone marrow from the
femoral canal, pieces of subchondral acetabular bone, and
fragments of bone from femoral neck and head. Our data
conﬁrmed that BMCs are the most versatile multipotent cells
as they display a similar adipogenic, chondrogenic, and oste-
ogenic potential. In addition, we demonstrated that FC pos-
sess a signiﬁcantly higher osteogenic potential compared to
AC. Thus, these cells are probably precommitted to the oste-
ogenic lineage. This novel ﬁnding may be important for the
development of new techniques of bone stock restoration
and also new strategies of bone tissue engineering. Indeed,
the intrinsic osteogenic precommitment of these cells may
potentially allow for a faster and better bone repair.
In conclusion, to answer our initial question, the harvest-
ing site does inﬂuence the osteogenic potential of multipotent
cells in an in vitro setting. In vivo studies will be necessary to
conﬁrm our preliminary results.
Data Availability
The GraphPad Prism ﬁles and all the cytometry data used
to support the ﬁndings of this study are available from the
corresponding author upon request.
Additional Points
The project number L1033 is registered with ClinicalTrials.-
gov NCT03369457.
Conflicts of Interest
The authors declare no conﬂict of interest regarding the
publication of this paper.
Acknowledgments
This study was supported by Ricerca Corrente grant of the
Italian Ministry of Health assigned to Laura Mangiavini.
References
[1] OECD, Health at a Glance 2017 Report, OECD Publishing,
2017.
[2] K. H. Maradit, D. R. Larson, C. S. Crowson et al., “Prevalence
of total hip and knee replacement in the United States,” The
Journal of Bone and Joint Surgery-American Volume, vol. 97,
no. 17, pp. 1386–1397, 2015.
[3] B. M. Wroblewski, P. D. Siney, and P. A. Fleming, “The
Charnley hip replacement -43 years of clinical success,” Acta
chirurgiae orthopaedicae et traumatologiae Čechoslovaca,
vol. 73, no. 1, pp. 6–9, 2006.
[4] V. M. Goldberg, “Selection of bone grafts for revision total hip
arthroplasty,” Clinical Orthopaedics and Related Research,
vol. 381, pp. 68–76, 2000.
[5] T. Albrektsson and C. Johansson, “Osteoinduction, osteocon-
duction and osseointegration,” European Spine Journal,
vol. 10, Supplement 2, pp. S96–101, 2001.
[6] M. R. Whitehouse and A. W. Blom, “The use of ceramics as
bone substitutes in revision hip arthroplasty,” Materials,
vol. 2, no. 4, pp. 1895–1907, 2009.
[7] V. Campana, G. Milano, E. Pagano et al., “Bone substitutes in
orthopaedic surgery: from basic science to clinical practice,”
Journal of Materials Science: Materials in Medicine, vol. 25,
no. 10, pp. 2445–2461, 2014.
12 Stem Cells International
[8] R. S. Gali, S. K. Devireddy, N. M. Rao et al., “Autogenous bone
marrow aspirate coated synthetic hydroxyapatite for recon-
struction of maxillo-mandibular osseous defects: a prospective
study,” Journal of Maxillofacial and Oral Surgery, vol. 16, no. 1,
pp. 71–78, 2017.
[9] S. M. Rabiee, S. M. J. Mortazavi, F. Moztarzadeh et al., “Asso-
ciation of a synthetic bone graft and bone marrow cells as a
composite biomaterial,” Biotechnology and Bioprocess Engi-
neering, vol. 14, no. 1, pp. 1–5, 2009.
[10] P. Kalia, M. J. Coathup, S. Oussedik et al., “Augmentation of
bone growth onto the acetabular cup surface using bone
marrow stromal cells in total hip replacement surgery,” Tissue
Enginerring Part A, vol. 15, no. 12, pp. 3689–3696, 2009.
[11] M. Pierini, B. Dozza, E. Lucarelli et al., “Eﬃcient isolation and
enrichment of mesenchymal stem cells from bone marrow,”
Cytotherapy, vol. 14, no. 6, pp. 686–693, 2012.
[12] R. Tuli, S. Tuli, S. Nandi et al., “Characterization of multi-
potential mesenchymal progenitor cells derived from human
trabecular bone,” Stem Cells, vol. 21, no. 6, pp. 681–693,
2003.
[13] R. Tasso, M. Gaetani, E. Molino et al., “The role of bFGF on the
ability of MSC to activate endogenous regenerative mecha-
nisms in an ectopic bone formation model,” Biomaterials,
vol. 33, no. 7, pp. 2086–2096, 2012.
[14] P. Coipeau, P. Rosset, A. Langonné et al., “Impaired diﬀeren-
tiation potential of human trabecular bone mesenchymal
stromal cells from elderly patients,” Cytotherapy, vol. 11,
no. 5, pp. 584–594, 2009.
[15] V. T. Nguyen, R. Cancedda, and F. Descalzi, “Platelet lysate
activates quiescent cell proliferation and reprogramming in
human articular cartilage: involvement of hypoxia inducible
factor 1,” Journal of Tissue Engineering and Regenerative
Medicine, vol. 12, no. 3, pp. e1691–e1703, 2018.
[16] A. W. Cheng, T. V. Stabler, M. Bolognesi, and V. B. Kraus,
“Selenomethionine inhibits IL-1β inducible nitric oxide
synthase (iNOS) and cyclooxygenase 2 (COX2) expression in
primary human chondrocytes,” Osteoarthritis and Cartilage,
vol. 19, no. 1, pp. 118–125, 2011.
[17] M. Mumme, C. Scotti, A. Papadimitropoulos et al., “Interleu-
kin-1β modulates endochondral ossiﬁcation by human adult
bone marrow stromal cells,” European Cells and Materials,
vol. 24, pp. 224–236, 2012.
[18] C. Scotti, E. Piccinini, H. Takizawa et al., “Engineering of a
functional bone organ through endochondral ossiﬁcation,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 110, no. 10, pp. 3997–4002, 2013.
[19] K. J. Livak and T. D. Schmittgen, “Analysis of relative gene
expression data using real-time quantitative PCR and the
2(-delta delta C(T)) method,” Methods, vol. 25, no. 4,
pp. 402–408, 2001.
[20] M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria
for deﬁning multipotent mesenchymal stromal cells. The
International Society for Cellular Therapy position statement,”
Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006.
[21] T. D. Schmittgen and B. A. Zakrajsek, “Eﬀect of experimental
treatment on housekeeping gene expression: validation by
real-time, quantitative RT-PCR,” Journal of Biochemical and
Biophysical Methods, vol. 46, no. 1�2, pp. 69–81, 2000.
[22] K. Pelttari, E. Steck, and W. Richter, “The use of mesenchymal
stem cells for chondrogenesis,” Injury, vol. 39, no. 1, pp. 58–65,
2008.
[23] G. R. Beck Jr., B. Zerler, and E. Moran, “Phosphate is a speciﬁc
signal for induction of osteopontin gene expression,” Proceed-
ings of the National Academy of Sciences of the United States of
America, vol. 97, no. 15, pp. 8352–8357, 2000.
[24] C. M. McLeod and R. L. Mauck, “On the origin and impact of
mesenchymal stem cell heterogeneity: new insights and
emerging tools for single cell analysis,” European Cells and
Materials, vol. 34, pp. 217–231, 2017.
[25] M. Pevsner-Fischer, S. Levin, and D. Zipori, “The origins of
mesenchymal stromal cell heterogeneity,” Stem Cell Reviews
and Reports, vol. 7, no. 3, pp. 560–568, 2011.
[26] D. G. Phinney, “Functional heterogeneity of mesenchymal
stem cells: implications for cell therapy,” Journal of Cellular
Biochemistry, vol. 113, no. 9, pp. 2806–2812, 2012.
[27] N. J. Sarma, A. T. NJ, and N. R. Yaseen, “Colony forming cell
(CFC) assay for human hematopoietic cells,” Journal of Visual-
ized Experiments, vol. 18, no. 46, article 2195, 2010.
[28] R. Veyrat-Masson, N. Boiret-Dupré, C. Rapatel et al., “Mesen-
chymal content of fresh bone marrow: a proposed quality con-
trol method for cell therapy,” British Journal of Haematology,
vol. 139, no. 2, pp. 312–320, 2007.
[29] M. F. Pittenger, A. M. Mackay, S. C. Beck et al., “Multilineage
potential of adult human mesenchymal stem cells,” Science,
vol. 284, no. 5411, pp. 143–147, 1999.
[30] G. Cox, S. A. Boxall, P. V. Giannoudis et al., “High abundance
of CD271+ multipotential stromal cells (MSCs) in intramedul-
lary cavities of long bones,” Bone, vol. 50, no. 2, pp. 510–517,
2012.
[31] P. Bianco, “Minireview: the stem cell next door: skeletal and
hematopoietic stem cell “niches” in bone,” Endocrinology,
vol. 152, no. 8, pp. 2957–2962, 2011.
[32] A. Ehninger and A. Trumpp, “The bone marrow stem cell
niche grows up: mesenchymal stem cells and macrophages
move in,” Journal of Experimental Medicine, vol. 208, no. 3,
pp. 421–428, 2011.
[33] Y. Kfoury and D. T. Scadden, “Mesenchymal cell contributions
to the stem cell niche,” Cell Stem Cell, vol. 16, no. 3, pp. 239–
253, 2015.
[34] N. Asada, S. Takeishi, and P. S. Frenette, “Complexity of bone
marrow hematopoietic stem cell niche,” International Journal
of Hematology, vol. 106, no. 1, pp. 45–54, 2017.
13Stem Cells International
Hindawi
www.hindawi.com
 International Journal of
Volume 2018
Zoology
Hindawi
www.hindawi.com Volume 2018
 Anatomy 
Research International
Peptides
International Journal of
Hindawi
www.hindawi.com Volume 2018
Hindawi
www.hindawi.com Volume 2018
Journal of 
Parasitology Research
Genomics
International Journal of
Hindawi
www.hindawi.com Volume 2018
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2013www.hindawi.com
The Scientific 
World Journal
8
Hindawi
www.hindawi.com Volume 2018
Bioinformatics
Advances in
Marine Biology
Journal of
Hindawi
www.hindawi.com Volume 2018
Hindawi
www.hindawi.com Volume 2018
Neuroscience 
Journal
Hindawi
www.hindawi.com Volume 2018
BioMed 
Research International
Cell Biology
International Journal of
Hindawi
www.hindawi.com Volume 2018
Hindawi
www.hindawi.com Volume 2018
Biochemistry 
Research International
Archaea
Hindawi
www.hindawi.com Volume 2018
Hindawi
www.hindawi.com Volume 2018
Genetics 
Research International
Hindawi
www.hindawi.com Volume 2018
Advances in
Virolog y Stem Cells International
Hindawi
www.hindawi.com Volume 2018
Hindawi
www.hindawi.com Volume 2018
Enzyme 
Research
Hindawi
www.hindawi.com Volume 2018
International Journal of
Microbiology
Hindawi
www.hindawi.com
Nucleic Acids
Journal of
Volume 2018
Submit your manuscripts at
www.hindawi.com
